Meeder Asset Management Inc Bridge Bio Pharma, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$27.35 - $40.45 $2,242 - $3,316	82 New	82 $2,000
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $23,146 - $108,635	-2,034 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$46.87 - $64.24 $30,418 - $41,691	649 Added 46.86%	2,034 $95,000
Q2 2021 Aug 09, 2021	SELL	$46.47 - $63.93 $75,746 - $104,205	-1,630 Reduced 54.06%	1,385 $84,000
Q1 2021 Apr 28, 2021	BUY	$55.47 - $72.35 $167,242 - $218,135	3,015 New	3,015 $185,000
Q4 2020 Feb 09, 2021	SELL	$38.38 - $71.11 $78,755 - $145,917	-2,052 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$27.2 - $42.19 $9,683 - $15,019	356 Added 20.99%	2,052 $77,000
Q2 2020 Aug 11, 2020	BUY	$22.22 - $35.69 $36,507 - $58,638	1,643 Added 3100.0%	1,696 $57,000
Q1 2020 May 15, 2020	BUY	$16.11 - $36.23 $853 - $1,920	53 New	53 $2,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.